Navigating Challenges: The Future of Lycos and MDMA Branding

This chapter delves into the financial challenges faced by Lycos, including their recent decision to conduct another phase three trial post-FDA setback. The discussion highlights the uncertainties surrounding their commercialization efforts and invites listener feedback on potential branding for MDMA, contingent on its approval.